Results 91 to 100 of about 9,994 (168)

Structural and Mechanistic Insights into Dual Cholinesterase Inhibition by Marine Phytohormones. [PDF]

Mar Drugs
Youn K, Soriano LM, Jun M.
europepmc   +1 more source

Differential cognitive enhancer effects of acetylcholinesterase inhibitors and memantine on age-related deficits in vigilance and sustained attention: a preclinical validation study. [PDF]

Behav Brain Funct
Bali ZK, Bruszt N, Göntér K, Hernádi I.   +3 more
europepmc   +1 more source

Antioxidant, antimicrobial, and anticholinesterase activities of A. nitida leaf extract mediated silver nanoparticles. [PDF]

Sci Rep
Zahoor M, Khan S, Khan RS, Islam NU, Ikram M, Alotaibi A.   +5 more
europepmc   +1 more source

The cholinergic drug galantamine ameliorates acute and subacute peripheral and brain manifestations of acute respiratory distress syndrome in mice. [PDF]

Sci Rep
Falvey A, Palandira SP, Chaudhry S, Tynan A, Consolim-Colombo FM, Metz CN, Brines M, Chang EH, Chavan SS, Tracey KJ, Pavlov VA.   +10 more
europepmc   +1 more source

Medicinal compounds and biotechnology of Amaryllidaceae alkaloids in <i>Lycoris radiata</i>. [PDF]

Front Plant Sci
Chen JX, Zheng J, Cai YM, Xu JX, Sun Y, Yang Z, Yang F, Chen MX, Chen Y, Li QZ.   +9 more
europepmc   +1 more source

Design, synthesis, and multitarget evaluation of thiosemicarbazone-sulfonamide hybrids as potent cholinesterase and MAO-A inhibitors with neuroblastoma-associated cytotoxicity. [PDF]

Sci Rep
Abbas K, Elamin MR, Şenol H, Çakır F, Taslimi P, Tokali FS, Raza N, Salem ME, Alharthy RD, Rasool A, Shafiq Z.   +10 more
europepmc   +1 more source

Deciphering the mechanisms underlying the dual-target inhibition of carbohydrate-digesting and neurodegenerative enzymes by Syzygium aromaticum (L.) Merr. & L.M. via molecular docking and dynamics simulations. [PDF]

Sci Rep
Ojo OA, Gyebi GA, Iyobhebhe M, Dada S, Daramola T, Ojo AB, Oyebamiji AK, Oyinloye BE, Ajiboye BO.   +8 more
europepmc   +1 more source

Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment. [PDF]

J Alzheimers Dis
Heo RJ, Negida A, Barrett MJ, Chrenka EA, Bayram E, Kane JPM, Werner AM, Rossom RC, Wyman-Chick KA.   +8 more
europepmc   +1 more source

Network meta-analysis of the efficacy of pharmacological treatments for post-stroke cognitive impairment and vascular cognitive impairment. [PDF]

Front Neurol
Li W, Liu X, Gao C, Li W, Liao X.
europepmc   +1 more source